A clinical pharmacology study of E3810 [rabeprazole] with pre- and post-treatment pH monitoring in patients with non-erosive gastroesophageal reflux disease.
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2011
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- 04 Oct 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 31 Jul 2007 Status changed from in progress to completed.
- 06 Nov 2005 New trial record.